UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$591M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$493M |
| 3 |
Broadcom
AVGO
|
+$481M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$460M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$503M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$370M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$368M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$279M |
| 5 |
Fidelity National Information Services
FIS
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.13% |
| 2 | Financials | 7.1% |
| 3 | Healthcare | 6% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Industrials | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Guardant Health
GH
$22.4B
| $4.09M | ﹤0.01% |
151,191
+67,458
| +81% | +$1.77M |
|
3002
Chemours
CC
$2.2B
| $4.09M | ﹤0.01% |
129,526
-24,942
| -16% | -$677K |
|
3003
American Airlines Group
AAL
$9.93B
| $4.08M | ﹤0.01% |
296,667
+142,120
| +92% | +$1.78M |
|
3004
Medpace
MEDP
$16.8B
| $4.07M | ﹤0.01% |
13,291
+2,254
| +20% | +$608K |
|
3005
Iridium Communications
IRDM
$5.23B
| $4.07M | ﹤0.01% |
98,969
-8,433
| -8% | -$334K |
|
3006
CALL
Microchip Technology
MCHP
$44.2B
| $4.06M | ﹤0.01% |
45,000
+20,000
| +80% | +$1.63M |
|
3007
Belden
BDC
$5.28B
| $4.06M | ﹤0.01% |
52,503
+18,608
| +55% | +$1.38M |
|
|
ICVX
3008
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $4.05M | ﹤0.01% |
256,869
+242,325
| +1,666% | +$2.33M |
|
3009
BlackRock MuniHoldings California Quality Fund
MUC
$1.01B
| $4.05M | ﹤0.01% |
363,666
-111,258
| -23% | -$1.13M |
|
3010
Reaves Utility Income Fund
UTG
$3.59B
| $4.05M | ﹤0.01% |
151,292
-12,157
| -7% | -$311K |
|
3011
MaxLinear
MXL
$6.21B
| $4.03M | ﹤0.01% |
169,703
+133,971
| +375% | +$2.62M |
|
3012
Associated Banc-Corp
ASB
$5.92B
| $4.01M | ﹤0.01% |
187,354
+63,375
| +51% | +$1.14M |
|
|
HPF
3013
John Hancock Preferred Income Fund II
HPF
$345M
| $4M | ﹤0.01% |
253,641
+50,991
| +25% | +$743K |
|
3014
ScottsMiracle-Gro
SMG
$3.63B
| $4M | ﹤0.01% |
62,781
-27,895
| -31% | -$1.51M |
|
3015
Vishay Intertechnology
VSH
$5.08B
| $3.99M | ﹤0.01% |
166,651
-8,648
| -5% | -$201K |
|
3016
JFrog
FROG
$10.7B
| $3.99M | ﹤0.01% |
115,275
-4,654
| -4% | -$126K |
|
|
SCHR
3017
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $3.99M | ﹤0.01% |
160,442
-88,008
| -35% | -$2.13M |
|
3018
PUT
Spectrum Brands
SPB
$2.02B
| $3.99M | ﹤0.01% |
50,000
+20,000
| +67% | +$1.51M |
|
3019
PUT
Vornado Realty Trust
VNO
$7.26B
| $3.99M | ﹤0.01% |
141,100
-442,200
| -76% | -$10.5M |
|
3020
Capital Group US Multi-Sector Income ETF
CGMS
$5.4B
| $3.98M | ﹤0.01% |
147,347
+79,184
| +116% | +$2.06M |
|
3021
CALL
Halliburton
HAL
$28B
| $3.98M | ﹤0.01% |
+110,000
| New | +$4.23M |
|
|
3022
PUT
Halliburton
HAL
$28B
| $3.98M | ﹤0.01% |
+110,000
| New | +$4.23M |
|
3023
PUT
Teladoc Health
TDOC
$1.29B
| $3.98M | ﹤0.01% |
184,500
-75,000
| -29% | -$1.38M |
|
3024
VanEck Biotech ETF
BBH
$428M
| $3.97M | ﹤0.01% |
24,044
-3,021
| -11% | -$465K |
|
|
DOOR
3025
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $3.97M | ﹤0.01% |
46,911
+15,153
| +48% | +$1.31M |
|
Similar funds
UBS Group's Q4 2023 Portfolio in Review
As of Q4 2023, UBS Group held 10,649 positions worth $334B, up 15% from $290B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group deployed $10.5B of net new capital in Q4 2023, opening 1,223 new positions and adding to 4,779 existing holdings. Its largest new stake was Veralto: 498,566 shares worth $41M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $503M trimmed.
- UBS Group's largest Q4 2023 buy was Veralto: 498,566 shares worth $41M.
- UBS Group added most to UBS Group in Q4 2023, an estimated $591M increase.
- UBS Group's biggest Q4 2023 reduction was Invesco QQQ Trust, cutting an estimated $503M.
- UBS Group fully exited Activision Blizzard in Q4 2023, selling an estimated $370M.
- UBS Group's ten largest holdings make up 14% of its $334B portfolio in Q4 2023.
- UBS Group opened 1,223 new positions and closed 1,397 in Q4 2023.
- UBS Group's portfolio value rose 15% quarter-over-quarter to $334B.
Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.